Affirmative Action Efforts Reconsidered

TACTICAL RETREAT: Many institutions, fearing lawsuits, will abandon their affirmative action programs, predicts NACME's George Campbell, Jr. Universities are feeling the impact of recently approved anti-affirmative action initiatives that ban the consideration of a student's race in admissions decisions. Medical schools have seen a dramatic decrease in minority enrollment; grad schools also have seen a noticeable decline. In hopes of maintaining diverse student bodies, many institutions-includ

Written byStephen Hoffert
| 11 min read

Register for free to listen to this article
Listen with Speechify
0:00
11:00
Share

George Campbell
TACTICAL RETREAT: Many institutions, fearing lawsuits, will abandon their affirmative action programs, predicts NACME's George Campbell, Jr.
Universities are feeling the impact of recently approved anti-affirmative action initiatives that ban the consideration of a student's race in admissions decisions. Medical schools have seen a dramatic decrease in minority enrollment; grad schools also have seen a noticeable decline. In hopes of maintaining diverse student bodies, many institutions-including the National Science Foundation-have turned to outreach programs to attract minority students. But the latest attacks on affirmative action have challenged the legality of such programs. Fearing lawsuits, many universities and public institutions are reconsidering using race as a factor in admissions and awards decisions.

"Most universities have affirmative action programs which are carefully constructed and can withstand judicial scrutiny," notes George Campbell, Jr., president and CEO of the National Action Council for Minorities in Engineering Inc. "But as more cases go to court, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies